CONMED Corporation has announced new compensation terms for its outgoing Chief Financial Officer, Todd Garner, following the announcement of his separation from the company effective on the earlier of March 15, 2026, or upon the appointment of a new CFO. Mr. Garner will remain with the company through November 2, 2026, during a Consulting Period, receiving his current base salary and remaining eligible for a pro-rated annual cash bonus for his 2026 service, based on his 2025 target bonus opportunity. He will not receive an annual equity award grant in the first quarter of 2026. Mr. Garner will continue to participate in company benefit plans during the Consulting Period, and, subject to certain conditions, his outstanding company equity awards will continue to vest through November 2, 2026. Upon separation as CFO, he will receive severance benefits in accordance with CONMED’s Executive Severance Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001174947-26-000017), on January 08, 2026, and is solely responsible for the information contained therein.